Director Edward D. Breen filed a Form 4 with the SEC on November 9, 2026, disclosing a same-day exercise and sale of 89,845 stock options in DuPont de Nemours, Inc. (NYSE:DD) on November 5, 2026, along with a prior grantor retained annuity trust transaction dated August 28, 2026.

Key Highlights

  • Option exercise: Breen exercised 89,845 Stock Options (Right to Buy NQOs) on November 5, 2026, at an exercise price of $108.84 per share.
  • Same-day sale: All 89,845 shares acquired through the exercise were sold on November 5, 2026, at a weighted average price of $146.4176, with individual trades ranging from $144.04 to $149.28, according to the filing.
  • GRAT transaction: On August 28, 2026, 35,551 shares were acquired at $0 per share (transaction code G), described as an annuity payment back to Breen from a 2024 GRAT 9.
  • Resulting ownership: Following the reported transactions, Breen directly beneficially owned 127,275.5715 shares of common stock, which the filing notes includes shares acquired pursuant to dividend reinvestment.
  • Options extinguished: The 89,845 options, which had an expiration date of February 1, 2027, were fully disposed of, leaving Breen with zero options in that grant, according to the filing.
  • Filing signed by attorney: The form was signed by Paige Fleming by Power of Attorney on November 9, 2026.

Breen's November 2026 Option Exercise and Share Sale at DuPont de Nemours

According to the Form 4 filed with the SEC, Edward D. Breen, listed as a Director of DuPont de Nemours, Inc. (NYSE:DD), reported three distinct transactions. The most recent, dated November 5, 2026, involved the exercise (transaction code M) of 89,845 Stock Options (Right to Buy NQOs) at a conversion price of $108.84 per share. The filing notes these options became exercisable in three substantially equal installments beginning on the first anniversary of the grant, and that "option shares may be used to satisfy withholding taxes." The options carried an expiration date of February 1, 2027.

On the same date, all 89,845 shares were sold (transaction code S) at a weighted average price of $146.4176. The filing states that trades ranged from $144.04 to $149.28, and that "upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price." After these transactions, Breen's direct beneficial ownership stood at 127,275.5715 shares.

A separate earlier transaction, dated August 28, 2026, recorded the acquisition of 35,551 shares at $0 (transaction code G, with a "V" designation), described in the filing as an "annuity payment back to Mr. Breen from 2024 GRAT 9." The filing also notes that Breen's total share count includes shares acquired through dividend reinvestment. The form was filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.

What Was Disclosed

The filing disclosed an option exercise and same-day sale of 89,845 DuPont common shares by Director Edward D. Breen on November 5, 2026, plus a prior GRAT annuity payment of 35,551 shares on August 28, 2026, leaving Breen with direct ownership of 127,275.5715 shares.